Pfizer to Postpone Some Drug Price Increases, After Criticism From Trump

Wednesday, July 11, 2018 - 08:40 in Mathematics & Economics

The company said it would roll back increases that took effect July 1 to give the president a chance to work on his “blueprint” to lower prices and to “provide more access for patients.”

Read the whole article on NY Times Health

More from NY Times Health

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net